Santen Pharmaceutical
4536.T
$9.61
Share price
1.46%
Change (1 day)
22.26%
Change (1 year)
Categories
EPS for Santen Pharmaceutical (4536.T)
EPS in 2023 (TTM): -$0.19
According to Santen Pharmaceutical 's latest financial reports the company's current EPS (TTM) is -$0.19. In 2022 the company made an earnings per share (EPS) of -$0.12 a decrease over its 2021 EPS that were of $0.17.
EPS history for Santen Pharmaceutical from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.19 | 59.97% |
| 2022 | -$0.12 | -172.6% |
| 2021 | $0.17 | -71.16% |
| 2020 | $0.58 | -12.81% |
| 2019 | $0.66 | -5.39% |
| 2018 | $0.70 | -0.15% |
| 2017 | $0.70 | 49.24% |
| 2016 | $0.47 | -58.85% |
| 2015 | $1.14 | 138.45% |
| 2014 | $0.48 | 10.85% |
| 2013 | $0.43 | -9.52% |
| 2012 | $0.48 | -23.1% |
| 2011 | $0.62 | 31.24% |
| 2010 | $0.47 | 0.99% |
| 2009 | $0.47 |